e-learning
resources
Virtual 2020
Pre-Congress Content
Management issues in thoracic oncology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evolution in the pathological study of lung cancer
A. Martinez Mesa (Malaga, Spain), N. Reina Marfil (Malaga, Spain), E. Cabrera Cesar (Malaga, Spain), A. Aguilar Galvez (Malaga, Spain), E. Sanchez (Malaga, Spain), M. Fernandez Aguirre (Malaga, Spain)
Source:
Virtual Congress 2020 – Management issues in thoracic oncology
Session:
Management issues in thoracic oncology
Session type:
E-poster session
Number:
2918
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Martinez Mesa (Malaga, Spain), N. Reina Marfil (Malaga, Spain), E. Cabrera Cesar (Malaga, Spain), A. Aguilar Galvez (Malaga, Spain), E. Sanchez (Malaga, Spain), M. Fernandez Aguirre (Malaga, Spain). Evolution in the pathological study of lung cancer. 2918
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Related content which might interest you:
Epigenetics and lung cancer
Source: Annual Congress 2006 - Epigenetics and respiratory disease
Year: 2006
The evaluation of lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 323s
Year: 2005
Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy
Source: Eur Respir J 2012; 39: 1437-1442
Year: 2012
Prognostic value study of lung cancer molecular markers and value of mitochondrial activity in resected non-small cell lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Evolution in the diagnostic approach to lung cancer
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Year: 2021
Aerosoltherapy in lung cancer
Source: Annual Congress 2008 - Therapy in thoracic oncology
Year: 2008
Venothromboembolism in lung cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 601s
Year: 2007
Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC)
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Lung cancer: immunopathology
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=48
Year: 2001
Epigenetics and lung cancer
Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications
Year: 2008
Comparison of clinic and pathological staging in non-small cell lung cancer
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010
Characteristics of lung cancer patients in Serbia and subsequent treatment in advanced NSCLC over time – epidemiology study
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017
Pathological profile of lung cancer in Tunisia
Source: Annual Congress 2012 - Epidemiology and care research of lung cancer
Year: 2012
A case series study on re-treatment to lung cancer after drug-induced interstitial lung disease
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018
Does the lung function affect the survival time in patients with resected non-small cell lung cancer?
Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery
Year: 2007
A study of the public‘s awareness of the causation of lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 184s
Year: 2005
Predictors of radiation-induced lung toxicity in patients with locally advanced non small cell lung cancer (NSCLC): a retrospective analysis
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept